Results 191 to 200 of about 39,486 (285)

Dosimetric effects of bladder volume changes in MR-guided radiotherapy for cervical cancer. [PDF]

BMC Cancer
Zhou K, Wang C, Zhao J, Chen J, An X, Yin Y, Li Z.   +6 more
europepmc   +1 more source

Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy—A Comprehensive Review

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Intrahepatic cholangiocarcinoma (iCCA) ranks as the second most common primary liver cancer, compared to about 20% of cases. Its global incidence has climbed over the past four decades, yet early detection remains indefinable due to its asymptomatic nature. Five‐year survival rate of approximately is under 10%.
Yaqoob Muhammad, YuZhu Jin, Kai Luo, He Bai, Xudong Zhang, Xu Sun, Zahoor Maheen, Ali Tanveer, Saeed Muddasar Muhammad, Jialin Qu, Guixin Zhang   +10 more
wiley   +1 more source

Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study. [PDF]

J Hepatocell Carcinoma
Su K, Liu X, Zeng YC, Xu J, Li H, Wang H, Du S, Wang H, Yue J, Yin Y, Li Z.   +10 more
europepmc   +1 more source

Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall [PDF]

, 2017
Bosch, Walter, Chundury, Anupama, Fischer-Valuck, Benjamin W, Gay, Hiram, Michalski, Jeff   +4 more
core   +2 more sources

Operationalizing a Decision‐Making for Adverse Event Reporting Toolkit (DART) for Aging and Serious Illness Research

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Introduction Monitoring adverse events (AEs) assures patient safety in clinical trials. Studies involving seriously ill and older adults can have a high volume of AEs related to underlying courses of illness rather than study procedures. Trials not regulated by the Food and Drug Administration (FDA) can incur excessive reporting burden beyond ...
Sara Lubetsky, Christopher Woodrell, Gabrielle Schiller, Brynn Bowman, Rachael Heitner, R. Sean Morrison, Albert L. Siu, Dalane Kitzman, Abigail Baim‐Lance   +8 more
wiley   +1 more source

MR-Guided Radiotherapy for Head and Neck Cancer: Current Developments, Perspectives, and Challenges. [PDF]

Front Oncol, 2021
Boeke S, Mönnich D, van Timmeren JE, Balermpas P.   +3 more
europepmc   +1 more source

Combined ablation and radiation therapy of spinal metastases: A novel multimodality treatment approach [PDF]

, 2015
Friedman, Michael V, Greenwood, Taylor J, Hillen, Travis J, Jennings, Jack W, Robinson, Clifford G, Wallace, Adam   +5 more
core   +1 more source

Conducting Medication Reviews: A Comparative Study Between ChatGPT‐4 and Healthcare Professionals

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background The increasing prevalence of patients with hyperpolypharmacy (> 10 medications) has made medication reviews increasingly complex. ChatGPT‐4‐Turbo (ChatGPT), a large language model, has demonstrated potential in healthcare applications and could potentially support medication reviews.
Simone M. K. ten Hoope, Sabrina Marongiu, Carl E. H. Siegert, Eibert R. Heerdink, Marjo J. A. Janssen, Fatma Karapinar‐Çarkit   +5 more
wiley   +1 more source

Gradient system characterization of a 1.5 T MR-Linac with application to 4D UTE imaging for adaptive MR-guided radiotherapy of lung cancer. [PDF]

Magn Reson Med
Goodburn R, Bruijnen T, Lecoeur B, Nair P, Ahmed M, Barnes H, Oelfke U, Wetscherek A.   +7 more
europepmc   +1 more source

Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results. [PDF]

J Clin Med, 2021
Sandoval ML, Youssef I, Latifi K, Grass GD, Torres-Roca J, Rosenberg S, Yamoah K, Johnstone PA.   +7 more
europepmc   +1 more source